Sector: Pharmaceuticals & Biotechnology

Large Cap

Gland Pharma Share Price

GLAND

₹2,811.90

-7.40(-0.26%)

24th Aug 2026 | 3:28 PM

NSE : GLAND

Open Free Demat Account

Gland Pharma Performance

Price Movement

₹2811.90

₹2791.00

₹2880.00

↘ Today's Low↗ Today's High

1 Year Performance

₹2811.90

₹1573.60

₹3039.80

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹2,880.00

Low₹2,791.00

Open at₹2,825.00

Prev Close₹2,819.30

Volumes5.18 L

Avg Price₹2,820.32

Lower Circuit₹2,255.50

Upper Circuit₹3,383.10

Historical Performance

3M High₹3,039.80

3M Low₹2,167.80

1 Yr High₹3,039.80

1 Yr Low₹1,573.60

3 Yr High₹3,039.80

3 Yr Low₹1,277.80

5 Yr High₹4,179.65

5 Yr Low₹861.00

Summary

As of 24-08-2026 23:59, Gland Pharma Ltd. share price today is ₹0, with a change of ₹-2819.30 (-100.00%) from the previous close of ₹2819.3. The stock opened at ₹2825 and traded between ₹2791 and ₹2880, with a total traded volume of 517520 shares. The company has a market capitalization of ₹46509.1 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹3039.8 and ₹1573.6, respectively.

Gland Pharma Ltd. valuation metrics include a P/E ratio of 41.2, EPS of ₹62.35, and book value of ₹4.40. Profitability indicators show ROE of 9.91% along with a dividend yield of 0.7%. Gland Pharma Ltd. has reported revenue of ₹6725.3 Cr and net profit of ₹1128.79 Cr.

Gland Pharma Ltd. technical indicators include Day RSI at 62.23, Day MFI at 79.3, Day ADX at 44.46. Additional indicators include Commodity Channel Index (CCI) at 50.2 and Williams %R at -43.35. Momentum indicators show Day MACD at 113.66, Day MACD Signal Line at 112.5, DayATR at 92.17. Rate of Change indicators for Gland Pharma Ltd. include ROC125 at 53.53 and ROC21 at 18.57.

Exponential moving averages include EMA5 at ₹2840.8, EMA10 at ₹2817.1, EMA12 at ₹2800, EMA20 at ₹2731.5, EMA26 at ₹2686.4, EMA50 at ₹2539.1, EMA100 at ₹2330.3, EMA200 at ₹2125.6. Simple moving averages include SMA5 at ₹2849.9, SMA10 at ₹2867, SMA20 at ₹2700.3, SMA30 at ₹2617.9, SMA50 at ₹2512.3, SMA100 at ₹2234.7, SMA150 at ₹2074.5, SMA200 at ₹1993.9.

Support levels for Gland Pharma are placed at First Support ₹2781.57, Second Support ₹2743.83, Third Support ₹2695.67. Resistance levels are seen at First Resistance ₹2867.47, Second Resistance ₹2915.63, Third Resistance ₹2953.37. Gland Pharma Ltd. shareholding pattern shows promoter holding at 51.77%, FII holding at 8.74%, DII holding at 0%, public holding at 9.06%.

Gland Pharma Fundamentals

Market Cap

High in industry

46,509.10 Cr.

PE Ratio (TTM)

Above industry Median

41.20

Dividend Yield

Above industry Median

0.70

Net Profit TTM

46.6% incr over last year

1,128.79

Net Profit Growth

46.6% incr over last year

1,128.79

PEG Ratio

Above industry Median

0.90

ROE

29.9% incr over last year

9.91

Operating Revenue TTM

6,725.30

Operating Revenue Growth

17.6% incr over last year

Book Value

Above industry Median

4.40

MFI

MFI Overbought

79.30

RSI

RSI is mid-range

62.23

EPS (TTM)

62.35

Debt to Equity

0.02

Face Value

Operating Profit Margin Qtr.

24.15

Operating Profit Qtr.

489.37

Net Profit Qtr.

316.96

Operating Revenue Qtr.

1,800.27

PB Ratio

4.40

Gland Pharma Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Total Revenue	1,286.64	1,261.59	1,177.51	1,074.15	1,038.84
Operating Expense	813.13	753.88	755.89	699.26	679.99
Operating Profit	473.51	507.72	421.63	374.89	358.84
Depreciation	43.95	43.11	44.53	44.84	43.77
Interest	0.69	6.16	0.50	3.97	7.44
Tax	123.30	144.35	104.61	106.68	93.12
Net Profit	364.39	420.45	307.85	302	269.26

Gland Pharma Technicals

Gland Pharma Ltd. EMA & SMA

₹2811.90

-8.10 (-0.29%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹2840.8

Day EMA10 ₹2817.1

Day EMA12 ₹2800

Day EMA20 ₹2731.5

Day EMA26 ₹2686.4

Day EMA50 ₹2539.1

Day EMA100 ₹2330.3

Day EMA200 ₹2125.6

Gland Pharma Support and Resistance

Resistance

First Resistance₹2867.47

Second Resistance₹2915.63

Third Resistance₹2953.37

Support

First Support₹2781.57

Second Support₹2743.83

Third Support₹2695.67

Technical Indicators

Day RSI62.23

Day MFI79.30

Day ADX44.46

Day Commodity Channel Index50.20

William-43.35

Day MACD113.66

Day MACD Signal Line112.50

Day ATR92.17

Day ROC12553.53

Day ROC2118.57

Gland Pharma Shareholding Pattern

Held By	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoter	51.8	51.8	51.8	51.8	51.8	51.8
FII	6.9	7.4	7.9	7.6	7.3	8.7
DII	33.3	32.8	32.6	33	33.3	30.5
Public	8	7.9	7.6	7.6	7.5	9.1

Gland Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	1.21 L	2.58 L	46.86%
Week	2.52 L	4.19 L	60.24%
1 Month	3.75 L	9.5 L	39.50%
6 Month	2.57 L	5.81 L	44.28%

Gland Pharma SWOT Analysis

Strengths21

Weakness6

Opportunity5

Threats2

Benjamin Graham Value Screen

Strong Performer, Getting Expensive (DVM)

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over 1 Year

Companies with high TTM EPS Growth

Stringent DVM Screener

Weekly Screener: High Momentum Score Stocks (subscription)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Dividend yield greater than sector dividend yield

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Month

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing Revenue every quarter for the past 3 quarters

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

RSI indicating price strength

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Gland Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
11 Aug, 2026	20	FINAL	11 Aug, 2026	Equity Share
14 Aug, 2025	18	FINAL	14 Aug, 2025	Equity Share
16 Aug, 2024	20	FINAL	16 Aug, 2024	Equity Share

Gland Pharma Stock Comparison

Financials	Rubicon Research Ltd.	Anthem Biosciences Ltd.	Aurobindo Pharma Ltd.	Sun Pharmaceutical Industries Ltd.	Neuland Laboratories Ltd.	Ipca Laboratories Ltd.
Price (₹)	₹1,766	₹883.60	₹1,608	₹1,910	₹22,901	₹1,921
% Change	2.39%	1.39%	-0.82%	0.40%	-1.72%	0.51%
Revenue TTM (₹ Cr)	₹1,935.80	₹2,002.34	₹34,935.29	₹59,910.52	₹2,371.81	₹10,125.58
Net Profit TTM (₹ Cr)	₹288.22	₹575.94	₹3,940.28	₹12,095.58	₹497.77	₹1,309.80
PE TTM	99.10	85.20	23.90	37.70	60.10	37.00
1 Year Return	255.61	5.9	54.35	15.87	67.78	34.74
ROCE	24.32	27.56	13.73	19.45	23.10	17.23

Similar Stocks

GLAXO

GlaxoSmithKline Pharmaceuticals Ltd.

₹ 2930.00

+0.96%

PFIZER

Pfizer Ltd.

₹ 4886.00

-1.85%

ABBOTINDIA

Abbott India Ltd.

₹ 26450.00

+0.84%

TORNTPHARM

Torrent Pharmaceuticals Ltd.

₹ 4886.50

-0.20%

LUPIN

Lupin Ltd.

₹ 2188.00

-0.63%

DRREDDY

Dr. Reddy's Laboratories Ltd.

₹ 1190.00

+1.30%

CIPLA

Cipla Ltd.

₹ 1437.90

+0.40%

SAILIFE

Sai Life Science Ltd.

₹ 1436.80

-1.41%

EMCURE

Emcure Pharmaceuticals Ltd.

₹ 1862.00

-0.05%

MANKIND

Mankind Pharma Ltd.

₹ 2374.50

-0.40%

PPLPHARMA

Piramal Pharma Ltd.

₹ 212.43

-0.58%

ACUTAAS

Acutaas Chemicals Ltd.

₹ 3171.00

+0.06%

LAURUSLABS

Laurus Labs Ltd.

₹ 1801.00

-0.06%

ALKEM

Alkem Laboratories Ltd.

₹ 5350.00

-0.93%

BIOCON

Biocon Ltd.

₹ 409.40

-1.48%

DIVISLAB

Divi's Laboratories Ltd.

₹ 8496.00

-1.17%

GRANULES

Granules India Ltd.

₹ 857.00

-0.13%

AJANTPHARM

Ajanta Pharma Ltd.

₹ 3581.00

-1.62%

ZYDUSLIFE

Zydus Lifesciences Ltd.

₹ 1103.80

-1.45%

GLENMARK

Glenmark Pharmaceuticals Ltd.

₹ 2390.70

+3.14%

WOCKPHARMA

Wockhardt Ltd.

₹ 1902.00

+0.83%

FAQ's on GLAND

What is the current share price of Gland Pharma Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Gland Pharma Ltd. is ₹ 2811.9 on the NSE and ₹ 2812.8 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Gland Pharma Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Gland Pharma Ltd. is approximately ₹ 46509.1 Cr.

What are the PE and PB ratios for Gland Pharma Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Gland Pharma Ltd. is 41.2, and the Price-to-Book (PB) ratio is 4.4.

What is the 52-Week High and Low for Gland Pharma Ltd.?

Over the past 52 weeks, the highest price reached by Gland Pharma Ltd. shares was ₹ 3039.8, and the lowest price was ₹ 1573.6.

What is the current dividend yield for Gland Pharma Ltd.?

As of 6 June 2025, the dividend yield for Gland Pharma Ltd. is 0.7%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Gland Pharma Ltd.?

Significant shareholdings in Gland Pharma Ltd. typically include entities such as:

Promoter
Mutual Funds
Public
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Gland Pharma Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Gland Pharma Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Gland Pharma Ltd.?

Gland Pharma Ltd. last declared a FINAL dividend of ₹ 20 per share for the financial period ending 2026. The record date was set as 2026-08-11, and the payment was/is scheduled around 2026-08-11. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy